Order Article Reprints

van der Kooij MK, Dekkers OM, Aarts MJB, van den Berkmortel FWPJ, Boers-Sonderen MJ, de Groot JWB, Hospers GAP, Piersma D, van Rijn RS, Suijkerbuijk KPM, et al. Sex-Based Differences in Treatment with Immune Checkpoint Inhibition and Targeted Therapy for Advanced Melanoma: A Nationwide Cohort Study. Cancers. 2021; 13(18):4639. https://doi.org/10.3390/cancers13184639

van der Kooij, Monique K., Olaf M. Dekkers, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Marye J. Boers-Sonderen, Jan Willem B. de Groot, Geke A. P. Hospers, Djura Piersma, Rozemarijn S. van Rijn, Karijn P. M. Suijkerbuijk, and et al. 2021. "Sex-Based Differences in Treatment with Immune Checkpoint Inhibition and Targeted Therapy for Advanced Melanoma: A Nationwide Cohort Study" Cancers 13, no. 18: 4639. https://doi.org/10.3390/cancers13184639

van der Kooij, M. K., Dekkers, O. M., Aarts, M. J. B., van den Berkmortel, F. W. P. J., Boers-Sonderen, M. J., de Groot, J. W. B., Hospers, G. A. P., Piersma, D., van Rijn, R. S., Suijkerbuijk, K. P. M., Westgeest, H. M., van der Veldt, A. A. M., Vreugdenhil, G., Wilgenhof, S., Wouters, M. W. J. M., Haanen, J. B. A. G., van den Eertwegh, A. J. M., & Kapiteijn, E. (2021). Sex-Based Differences in Treatment with Immune Checkpoint Inhibition and Targeted Therapy for Advanced Melanoma: A Nationwide Cohort Study. Cancers, 13(18), 4639. https://doi.org/10.3390/cancers13184639